Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)

详细信息    查看全文

• 作者：Gijs WD Landman (1)
  Jana V van Vliet-Ostaptchouk (2) (3)
  Nanne Kleefstra (1) (4) (5)
  Kornelis JJ van Hateren (1)
  Iefke Drion (1)
  Klaas H Groenier (6)
  Rijk OB Gans (5)
  Harold Snieder (7)
  Marten H Hofker (2)
  Henk JG Bilo (1) (5) (8)
  
• 关键词：Type 2 Diabetes ; CVD ; Mortality ; 9p21 ; Genetics ; SNP
• 刊名：Cardiovascular Diabetology
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：11
• 期：1
• 全文大小：300KB
• 参考文献：1. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. / JAMA 2002,287(19):2570鈥?581. CrossRef
  2. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, / et al.: Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. / Science 2007,316(5829):1336鈥?341. CrossRef
  3. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, / et al.: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. / Science 2007,316(5829):1341鈥?345. CrossRef
  4. Mit LU, Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Diabetes Genetics Initiative of Broad Institute of H Novartis Institutes of BioMedical R, / et al.: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. / Science 2007,316(5829):1331鈥?336. CrossRef
  5. Cugino D, Gianfagna F, Santimone I, de Gaetano G, Donati MB, Iacoviello L, Di Castelnuovo A: Type 2 diabetes and polymorphisms on chromosome 9p21: A meta-analysis. / Nutr Metab Cardiovasc Dis 2012,22(8):619鈥?25. CrossRef
  6. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, / et al.: A common variant on chromosome 9p21 affects the risk of myocardial infarction. / Science 2007,316(5830):1491鈥?493. CrossRef
  7. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, / et al.: A common allele on chromosome 9 associated with coronary heart disease. / Science 2007,316(5830):1488鈥?491. CrossRef
  8. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A, Jones GT, Rinkel GJ, Blankensteijn JD, Ronkainen A, / et al.: The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. / Nat Genet 2008,40(2):217鈥?24. CrossRef
  9. Gioli-Pereira L, Santos PC, Ferreira NE, Hueb WA, Krieger JE, Pereira AC: Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21. / BMC Cardiovasc Disord 2012, 12:61. CrossRef
  10. Virani SS, Brautbar A, Lee VV, MacArthur E, Morrison AC, Grove ML, Nambi V, Frazier L, Wilson JM, Willerson JT, / et al.: Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. / Circ J 2012,76(4):950鈥?56. CrossRef
  11. Wang W, Peng W, Zhang X, Lu L, Zhang R, Zhang Q, Wang L, Chen Q, Shen W: Chromosome 9p21.3 polymorphism in a Chinese Han population is associated with angiographic coronary plaque progression in non-diabetic but not in type 2 diabetic patients. / Cardiovasc Diabetol 2010, 9:33. CrossRef
  12. Doria A, Wojcik J, Xu R, Gervino EV, Hauser TH, Johnstone MT, Nolan D, Hu FB, Warram JH: Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. / JAMA 2008,300(20):2389鈥?397. CrossRef
  13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. / Diabetes Care 1997,20(7):1183鈥?197.
  14. Ellis KL, Pilbrow AP, Frampton CM, Doughty RN, Whalley GA, Ellis CJ, Palmer BR, Skelton L, Yandle TG, Palmer SC, / et al.: A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality. / Circ Cardiovasc Genet 2010,3(3):286鈥?93. CrossRef
  15. Muehlschlegel JD, Liu KY, Perry TE, Fox AA, Collard CD, Shernan SK, Body SC, Investigators CG: Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. / Circulation 2010,122(11 Suppl):S60鈥?5. CrossRef
  16. Silander K, Tang H, Myles S, Jakkula E, Timpson NJ, Cavalli-Sforza L, Peltonen L: Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. / Genome Med 2009,1(5):51. CrossRef
  17. Brito EC, Lyssenko V, Renstrom F, Berglund G, Nilsson PM, Groop L, Franks PW: Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults. / Diabetes 2009,58(6):1411鈥?418. CrossRef
  18. Cotsapas C, Prokunina-Olsson L, Welch C, Saxena R, Weaver C, Usher N, Guiducci C, Bonakdar S, Turner N, LaCroix B, / et al.: Expression analysis of loci associated with type 2 diabetes in human tissues. / Diabetologia 2010,53(11):2334鈥?339. CrossRef
  19. Visel A, Zhu Y, May D, Afzal V, Gong E, Attanasio C, Blow MJ, Cohen JC, Rubin EM, Pennacchio LA: Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. / Nature 2010,464(7287):409鈥?12. CrossRef
  20. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, Ren B, Fu XD, Topol EJ, Rosenfeld MG, / et al.: 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. / Nature 2011,470(7333):264鈥?68. CrossRef
  21. Musunuru K, Post WS, Herzog W, Shen H, O鈥機onnell JR, McArdle PF, Ryan KA, Gibson Q, Cheng YC, Clearfield E, / et al.: Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for increased vascular disease. / Circ Cardiovasc Genet 2010,3(5):445鈥?53. CrossRef
  22. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjonneland A, / et al.: General and abdominal adiposity and risk of death in Europe. / N Engl J Med 2008,359(20):2105鈥?120. CrossRef
  23. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R, Prospective Studies C: Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. / Lancet 2009,373(9669):1083鈥?096. CrossRef
  24. Beekman M, Nederstigt C, Suchiman HE, Kremer D, van der Breggen R, Lakenberg N, Alemayehu WG, de Craen AJ, Westendorp RG, Boomsma DI, / et al.: Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity. / Proc Natl Acad Sci U S A 2010,107(42):18046鈥?8049. CrossRef
  25. Meyer TE, Boerwinkle E, Morrison AC, Volcik KA, Sanderson M, Coker AL, Pankow JS, Folsom AR: Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study. / Cancer Epidemiol Biomarkers Prev 2010,19(2):558鈥?65. CrossRef
  26. Pierce BL, Ahsan H: Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. / Hum Hered 2010,69(3):193鈥?01. CrossRef
  27. Landman GW, van Hateren KJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ: The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11). / Br J Gen Pract 2010,60(572):172鈥?75. CrossRef
  28. Shea J, Agarwala V, Philippakis AA, Maguire J, Banks E, Depristo M, Thomson B, Guiducci C, Onofrio RC, Kathiresan S, / et al.: Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction. / Nat Genet 2011,43(8):801鈥?05. CrossRef
  29. Chen SN, Ballantyne CM, Gotto AM Jr, Marian AJ: The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis. / BMC Cardiovasc Disord 2009, 9:3. CrossRef
  
• 作者单位：Gijs WD Landman (1)
  Jana V van Vliet-Ostaptchouk (2) (3)
  Nanne Kleefstra (1) (4) (5)
  Kornelis JJ van Hateren (1)
  Iefke Drion (1)
  Klaas H Groenier (6)
  Rijk OB Gans (5)
  Harold Snieder (7)
  Marten H Hofker (2)
  Henk JG Bilo (1) (5) (8)
  
  1. Diabetes Center, Isala Clinics, PO Box 10400, 8000 GK, Zwolle, The Netherlands
  2. Molecular Genetics, Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
  3. Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
  4. Langerhans, Medical Research Group, Zwolle, the Netherlands
  5. Department of Internal Medicine, University Medical Center Groningen, Groningen, the Netherlands
  6. Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
  7. Unit of Genetic Epidemiology and Bioinformatics, Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
  8. Department of Internal Medicine, Isala Clinics, Zwolle, the Netherlands
  

文摘

The genomic region at 9p21 chromosome near the CDKN2A/CDKN2B genes is associated with type 2 diabetes(T2D) and cardiovascular disease(CVD). The effect of the 9p21 locus on long-term mortality in patients with T2D has yet to be determined. We examined three single nucleotide polymorphisms (SNPs) on 9p21, consistently and independently associated with T2D (rs10811661) or CVD (rs10757278, rs2383206), in relation to the risk of total and cardiovascular mortality in diabetic patients. We also aimed to replicate the previously observed interaction between rs2383206 and glycemic control on mortality. Genotypes for three SNPs were determined in 914 individuals from a prospective cohort of T2D patients of Dutch origin. Associations with mortality were assessed using Cox proportional hazard analyses. After a median follow-up of 9.5 years, 358 out of 914 patients had died. The hazard ratio (HR) for total mortality among individuals homozygous for the T2D-risk allele of rs10811661 compared to non-homozygous individuals was 0.74(95%CI 0.59-0.93). For the carriers of both CVD-risk alleles of rs10757278, the HR for total mortality was 1.31(95%CI 1.01-1.70). We found a significant interaction between rs2383206 and HbA1c on mortality, which was higher among patients with two CVD-risk alleles in the two lowest HbA1c tertiles (HR 1.68(95%CI 1.08-2.63); HR 1.48(95%CI 1.01-2.18). In conclusion, common variants on 9p21 were associated with mortality in patients with T2D in a Dutch population. The T2D SNP was inversely associated with mortality, while the CVD SNP increased the risk for mortality. We confirmed a possible, although different, synergistic relationship between HbA1c and rs2383206 on total mortality.